You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Gynecologic Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 2 of 3 | Results 11 - 20 of 22

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Cancer, Cancer-Gynecologic

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Olaparib and Cediranib Maleate in Treating Patients With Recurrent, Refractory, or Metastatic Endometrial Cancer

Cancer, Cancer-Gynecologic

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Active

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Tashanna Myers, MD
Cancer-Gynecologic, Cancer

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Active

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Cancer-Gynecologic, Cancer

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer

The purpose of this study is to compare standard treatment, radiation therapy combined with the chemotherapy drug cisplatin, to standard chemo-radiation therapy plus additional experimental chemotherapy to see if it reduces the risk of tumor recurrence and improves overall survival.
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

The purpose of this study is to find out if radiation therapy along with the addition of the drugs, cisplatin and gemcitabine, works and to find out what side effects or surgical complications are caused by treatment with this combination.
Cancer-Gynecologic, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Recruiting

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

The purpose of this study is to test whether the use of a radiation therapy delivery technique called intensity-modulated radiation therapy (IMRT) can reduce the amount and severity of gastrointestinal side effects (such as diarrhea) that result from radiation, compared with standard radiation techniques
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

Studying paclitaxel to see how well it works compared to polyglutamate paclitaxel or observation only in treating patients

Cancer-Gynecologic

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Active

Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Cancer, Cancer-Gynecologic

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active
Page 2 of 3 | Results 11 - 20 of 22